AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2014
Jan 27, 2014
34117_dirs_2014-01-27_d7bd2e94-c3d2-443f-aa56-f2bbdd73abf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-23
Reporting Person: Titterton Lewis H jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-23 | Common Stock | P | 22800 | $0.27 | Acquired | 9966825 | Direct |
| 2014-01-23 | Common Stock | P | 100000 | $0.274 | Acquired | 10066825 | Direct |
| 2014-01-23 | Common Stock | P | 10000 | $0.28 | Acquired | 10076825 | Direct |
| 2014-01-23 | Common Stock | P | 67200 | $0.29 | Acquired | 10144025 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6